Sanofi Menactra Adverse Event Reports Prompt Letter To Providers
This article was originally published in The Pink Sheet Daily
Executive Summary
At FDA's request, Sanofi Pasteur is informing customers of five reported cases of Guillain Barre syndrome that occurred after administration of the mengingococcal vaccine.